Immix Biopharma Subsidiary Nexcella Appoints Mary Sue Coleman, former Johnson & Johnson Independent Director, to Board of Directors - Immix Biopharma (NASDAQ:IMMX)

Dr. Coleman joins the Nexcella, Inc. Board of Directors with over a decade of experience as an Independent Director of Johnson & Johnson from 2003-2016Dr. Coleman is President Emerita of the University of

Related Keywords

United States ,Michigan State University ,Michigan ,Cambridge ,Cambridgeshire ,United Kingdom ,American ,Gary Locke ,Mary Sue Coleman ,Johnson ,Ilya Rachman ,Suzanne Messere ,Los Angeles ,Gabriel Morris ,Emerita Of The University Michigan ,University Of North Carolina At Chapel Hill ,College Presidents ,Notre Dame University ,Gaylord Container Corp ,Company Board Of Directors ,American Association For The Advancement Of Science ,Institute Of Medicine ,University Of North Carolina ,Immix Biopharma Inc ,Nexcella Inc ,Manufacturing Partnership ,University Of Michigan Health System ,National Academy Of Medicine ,Dartmouth College ,Indiana University ,Cancer Center ,Meredith Corporation ,University Of Kentucky ,National Advisory Council On Innovation ,American Academy Of Arts ,University Of Michigan ,Board Of Trustees Society For Science ,Audit Committee ,National Collegiate Athletic Association ,Association Of American Universities ,Exchange Commission ,Jj Audit Committee ,Johns And Jamesl Knight Foundation ,University Of Denver ,Grinnell College ,Michigan Women Foundation ,University Of New Mexico ,Kavli Foundation ,University Of Iowa ,Jj Technology Science Rd Committee ,Independent Director ,President Emerita ,Michigan Health System ,Trustee Emerita ,Mayo Clinic ,Immix Biopharma ,Michigan Health ,Michigan Difference ,Chief Executive Officer ,Immixbio Chief Financial Officer ,Advanced Manufacturing Partnership ,Secretary Gary Locke ,National Advisory Council ,Gates Cambridge Scholarship ,American Universities ,American Academy ,American Association ,National Academy ,Gaylord Container ,New Mexico ,Vice Chancellor ,North Carolina ,Chapel Hill ,Michigan State ,Michigan Roundtable ,Michigan Women ,Trillium Lifetime Achievement ,Tissue Specific Therapeutics ,Orphan Drug Designation ,Rare Pediatric Disease Designation ,Risk Factor ,Annual Report ,